Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02334267 · ClinicalTrials.gov registry record · NA

Acid-Base Composition With Use of hemoDialysates

A NA study of End Stage Renal Disease, sponsored by Fresenius Medical Care North America.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT02334267 is a NA study of End Stage Renal Disease that has completed, run by Fresenius Medical Care North America. The registered enrollment target is 11 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02334267, a NA study of End Stage Renal Disease, has completed, sponsored by Fresenius Medical Care North America.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

This study is a prospective, single center, single blind (patient and laboratory), randomized, cross-over, two week investigation of intradialytic acid-base kinetics and physiology associated with use of two commercial acid dialysate concentrates in prevalent hemodialysis patients.

Conditions Studied

End Stage Renal Disease

Interventions

  • DEVICE Group 1: GranuFlo
  • DEVICE Group 2: NaturaLyte

Study Locations (1)

Tennessee

  • Volunteer Research Group and New Orleans Center for Clinical Research - Knoxville

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2014-11
Est. Completion 2015-09
Phase NA

Sponsor

Fresenius Medical Care North America

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02334267

The ClinicalTrials.gov registry entry for NCT02334267 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (99% lower). The listed sponsor is Fresenius Medical Care North America, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which Group 1: GranuFlo is the first listed.

NCT02334267 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT02334267 about?

NCT02334267 is a clinical study titled "Acid-Base Composition With Use of hemoDialysates". This study is a prospective, single center, single blind (patient and laboratory), randomized, cross-over, two week investigation of intradialytic acid-base kinetics and physiology associated with use of two commercial acid dialysate concentrates in prevalent hemodialysis patients.

What is the current status of trial NCT02334267?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2014-11. Estimated completion is 2015-09.

What conditions does trial NCT02334267 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT02334267?

The interventions under investigation include: Group 1: GranuFlo (DEVICE), Group 2: NaturaLyte (DEVICE).

Who is sponsoring clinical trial NCT02334267?

This trial is sponsored by Fresenius Medical Care North America, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02334267 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.